吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 24 2019

Full Issue

Continued Pressure On Medicaid Business Dampens Some Enthusiasm About Anthem's Better-Than-Expected Profits

Anthem's medical-loss ratio was higher than anticipated. The company said that the MLR has been pushed up by its Medicaid business, an issue it also flagged last quarter.

Anthem's third-quarter profit jumped 23%, and the Blue Cross-Blue Shield insurer raised its 2019 forecast after pulling in more people covered by Medicare Advantage and Medicaid. Anthem also gave investors an initial glimpse into next year's profit expectations. (Murphy, 10/23)

Anthem said on Wednesday medical costs in its Medicaid business, which manages health plans for low-income Americans, improved in the quarter even as overall costs rose and came in higher than Wall Street targets. "We're very positive about the overall Medicaid environment business going forward," Boudreaux said. The insurer reported third-quarter profit ahead of estimates and raised its full-year earnings forecast, riding on higher sales of its government-backed health plans. (Mathias and Humer, 10/23)

The health insurer also gave some initial projections for 2020, suggesting that adjusted earnings per share growth will be around the low end of its 12% to 15% targeted rate. Anthem also said it still expects its new pharmacy-benefit manager, IngenioRx, to produce gains of at least $800 million, or around $2.30 per share, next year. (Wilde Mathews and Sebastian, 10/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, August 7
  • Thursday, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF